Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients

OBJECTIVE - insulin Mix25 is a new premixed insulin analog containing 25% i nsulin lispro and 75% neutral protamine lispro (NPL) suspension (NPL insuli n). The aim of the study was to compare serum glucose and insulin responses after breakfast in type 2 diabetic patients who received Mix25, premixed r egular/NPH (30%/70%), or NPH insulin before the meal. RESEARCH DESIGN AND METHODS - We studied 22 type 2 diabetic patients of age 62 +/- 1 years, BMI 30 +/- 1 kg/m(2), duration of diabetes 15 +/- 2 years, duration of insulin therapy 6 +/- 1 years, insulin dose 65 +/- 6 U/day, an d HbA(1c) 7.9 +/- 0.2%. Ten healthy individuals (age 56 +/- 1 years, BMI 28 +/- 1 kg/m(2)) served as control subjects. Each patient (except healthy su bjects, who were studied once each) was studied three times in a double-bli nd, randomized fashion. After an overnight fast, the patients received 36 /- 4 U of test insulin. Ten minutes after insulin injection, the patients i ngested a breakfast meal (512 kcal, 60% carbohydrate, 20% fat, and 20% prot ein), identical in all studies. Blood samples were taken before and at 10- to 30-min intervals for 240 min after the breakfast meal. RESULTS - The peak rise in serum glucose was lower after Mix25 (76 +/- 7 mg /dl) than after 30/70 (94 +/- 5 mg/dl, P < 0.05) or NPH (113 +/- 4 mg/dl, P < 0.005) insulin. The incremental area under the serum glucose curve was 3 6% smaller after Mix25 than after 30/70 (P < 0.01) and 56% smaller than aft er NPH (P < 0.005) insulin. The peak rise in serum insulin concentration wa s higher after Mix25 (103 +/- 18 mU/l) than after 30/70 (87 +/- 13 mU/l, P < 0.05) or NPH (62 +/- 12 mU/l, P < 0.01) insulin. The incremental area und er the serum insulin curve was higher after Mix25 than after 30/70 during t he first 2-3 h (P < 0.02), but the difference disappeared by the end of the 4-h follow-up period. After Mix25 injection, there was an inverse correlat ion between the glucose response to a meal and insulin dose (r = -0.56, P < 0.01) or the incremental area under the serum insulin curve (r = -0.39, P < 0.05). No such correlations were observed with the other insulins. CONCLUSIONS - Because of its faster initial absorption rate, the new premix ed insulin analog Mix25 reduces blood glucose response to a breakfast meal in type 2 diabetic patients compared with premixed 30/70 (regular/NPH) or N PH insulin.